Newsletter | November 23, 2022

11.23.22 -- CDMO Selection In Our Post-COVID World

Featured Editorial
Industry Insights
Is Your Sterile Injectable Ready For Changes In Raw Materials?

Changes in raw materials are inevitable over a drug's lifespan, but even small modifications can throw your drug out of compliance. Learn how to safeguard drug integrity when raw materials change.

Evaluating The Impact Of Sterilization Methods On Stopper Performance

Three studies cover a product that aims to address unmet needs around the development of subcutaneous drug therapies for chronic disease treatment, including methods for sterilization and a human factors evaluation.

Investments, Capacity Expansion, And Improvements

An ongoing strategic growth plan is expanding our manufacturing capacity and services across geographies so that we are able to better meet increased demand and have improved lead times for key products.

News Headlines